Czogalla, B.; Dötzer, K.; Sigrüner, N.; von Koch, F.E.; Brambs, C.E.; Anthuber, S.; Frangini, S.; Burges, A.; Werner, J.; Mahner, S.;
et al. Combined Expression of HGFR with Her2/neu, EGFR, IGF1R, Mucin-1 and Integrin α2β1 Is Associated with Aggressive Epithelial Ovarian Cancer. Biomedicines 2022, 10, 2694.
https://doi.org/10.3390/biomedicines10112694
AMA Style
Czogalla B, Dötzer K, Sigrüner N, von Koch FE, Brambs CE, Anthuber S, Frangini S, Burges A, Werner J, Mahner S,
et al. Combined Expression of HGFR with Her2/neu, EGFR, IGF1R, Mucin-1 and Integrin α2β1 Is Associated with Aggressive Epithelial Ovarian Cancer. Biomedicines. 2022; 10(11):2694.
https://doi.org/10.3390/biomedicines10112694
Chicago/Turabian Style
Czogalla, Bastian, Katharina Dötzer, Nicole Sigrüner, Franz Edler von Koch, Christine E. Brambs, Sabine Anthuber, Sergio Frangini, Alexander Burges, Jens Werner, Sven Mahner,
and et al. 2022. "Combined Expression of HGFR with Her2/neu, EGFR, IGF1R, Mucin-1 and Integrin α2β1 Is Associated with Aggressive Epithelial Ovarian Cancer" Biomedicines 10, no. 11: 2694.
https://doi.org/10.3390/biomedicines10112694
APA Style
Czogalla, B., Dötzer, K., Sigrüner, N., von Koch, F. E., Brambs, C. E., Anthuber, S., Frangini, S., Burges, A., Werner, J., Mahner, S., & Mayer, B.
(2022). Combined Expression of HGFR with Her2/neu, EGFR, IGF1R, Mucin-1 and Integrin α2β1 Is Associated with Aggressive Epithelial Ovarian Cancer. Biomedicines, 10(11), 2694.
https://doi.org/10.3390/biomedicines10112694